伊利亚Stupka博士

Elia Stupka博士是健康促进会的战略顾问。世界杯葡萄牙vs加纳即时走地他是数字健康领域富有远见的领导者，对健康和生命科学的创新充满热情，在行业、学术和临床领域拥有20年的经验。在Dana-Farber Cancer Institute(世界领先的癌症组织之一)担任数据科学领导职务期间，Stupka博士将研究、临床和运营数据整合在一起，以改善患者的预后并发现新的治疗方法。1999年至2001年，他作为英国剑桥第一个人类基因组注释团队的成员开始了他的职业生涯。随后，他与诺贝尔奖得主悉尼·布伦纳(Sydney Brenner)合作，在新加坡建立了第一个基因组研究小组。随后，斯图普卡在几个关键的欧洲研究机构工作，如意大利那不勒斯的遗传学研究所和伦敦大学学院。随后，他在意大利米兰的圣拉斐尔医院(San Raffaele Hospital)与人共同领导了一个基因组学研究中心，在那里，他为欧洲第一个商业化可行的基因治疗临床试验的成功开发和完成做出了贡献。他在制药行业工作了几年，在勃林格殷格翰制药公司(Boehringer Ingelheim pharma)负责计算生物学和基因组学。他发表了100多篇同行评议文章，在药物开发、数据科学和伦理等领域被引用35000多次。他的工作有助于理解人类基因组和转录组，诊断罕见疾病患者，开发基因疗法和市场上的新药物，以及发展与健康和生物学大数据快速变化的世界相关的伦理框架。 In his role leading data science at Dana-Farber Cancer Institute, one of the world's leading cancer organizations, Dr. Stupka brought together research, clinical and operational data to improve patient outcomes and facilitated the discovery of new treatments. He started his career as a member of the first team that annotated the human genome in Cambridge, U.K. He then worked with Nobel Laureate Sydney Brenner to build the first genome research group in Singapore. Dr. Stupka has worked at several key European research organizations such as the Telethon Institute of Genetics and University College London. He then co-directed a genomics research center at San Raffaele Hospital in Milan, Italy, where he contributed to the successful development and completion of the first commercially viable gene therapy clinical trials in Europe. He worked several years in the pharma industry, at Boehringer Ingelheim Pharma, where he headed computational biology and genomics. Over his career Dr. Stupka has published 100+ peer reviewed articles, and been cited 35,000+ times across the fields of drug development, data science and ethics. His work has contributed to the understanding of the human genome and transcriptome, the diagnosis of rare disease patients, the development of gene therapy and novel drugs on the market and the development of ethics frameworks pertaining to the fast-changing world of big data in health and biology.